A share price of Teladoc Health Inc [TDOC] is currently trading at $9.01, up 6.25%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The TDOC shares have gain 10.42% over the last week, with a monthly amount glided 18.09%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Teladoc Health Inc [NYSE: TDOC] stock has seen the most recent analyst activity on July 25, 2025, when Mizuho initiated its Neutral rating and assigned the stock a price target of $10. Previously, Goldman started tracking the stock with Buy rating on November 15, 2024, and set its price target to $14. On September 17, 2024, Jefferies reiterated its Hold rating and revised its price target to $10 on the stock. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $22 on February 29, 2024. Leerink Partners initiated its recommendation with a Market Perform and recommended $17 as its price target on February 26, 2024. DA Davidson downgraded its rating to Neutral for this stock on January 17, 2024, and downed its price target to $22. In a note dated January 03, 2024, Barclays initiated an Overweight rating and provided a target price of $26 on this stock.
Teladoc Health Inc experienced fluctuations in its stock price throughout the past year between $6.35 and $15.21. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. Teladoc Health Inc [NYSE: TDOC] shares were valued at $9.01 at the most recent close of the market. An investor can expect a potential return of 10.99% based on the average TDOC price forecast.
Analyzing the TDOC fundamentals
Trailing Twelve Months sales for Teladoc Health Inc [NYSE:TDOC] were 2.54B which represents -1.64% decline. Gross Profit Margin for this corporation currently stands at 0.7% with Operating Profit Margin at -0.11%, Pretax Profit Margin comes in at -0.09%, and Net Profit Margin reading is -0.08%. To continue investigating profitability, this company’s Return on Assets is posted at -0.07, Equity is -0.14 and Total Capital is -0.11. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.72.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.42 points at the first support level, and at 7.82 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.69, and for the 2nd resistance point, it is at 10.36.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Teladoc Health Inc [NYSE:TDOC] is 2.59. Further, the Quick Ratio stands at 2.49, while the Cash Ratio is 1.69. Considering the valuation of this stock, the price to sales ratio is 0.63, the price to book ratio is 1.12.
Transactions by insiders
Recent insider trading involved Catapano Joseph Ronald, Chief Accounting Officer, that happened on Oct 02 ’25 when 2972.0 shares were sold. CHIEF EXECUTIVE OFFICER, DIVITA CHARLES III completed a deal on Sep 11 ’25 to sell 16787.0 shares. Meanwhile, Officer DIVITA CHARLES III bought 16787.0 shares on Sep 11 ’25.
